Search results for "complication"

showing 10 items of 2051 documents

Renal tumour surgery in elderly patients.

2008

OBJECTIVE To analyse morbidity, renal function and oncological outcome in patients aged ≥80 years who had surgery for renal tumours, as in the elderly such surgery is controversial in relation to life-expectancy and other causes of death. PATIENTS AND METHODS Between 1990 and 2006, in our institution 1625 patients had surgery to treat solid renal tumours suspected to be renal cell carcinoma (RCC); 62 (4%) were aged ≥80 years (mean 82.5), and 73% of these elderly patients had radical nephrectomy (RN) and 27% nephron-sparing surgery (NSS). Results The median (range) follow-up was 3.1 (0.2–14.1) years (89% of the patients). There was no perioperative mortality. There were only minor complicati…

NephrologyMalemedicine.medical_specialtyUrologymedicine.medical_treatmentRenal functionurologic and male genital diseasesNephrectomyDisease-Free SurvivalPostoperative ComplicationsRenal cell carcinomaInternal medicineMedicineHumansCarcinoma Renal CellSurvival analysisNeoplasm StagingRetrospective StudiesAged 80 and overbusiness.industryAge FactorsPerioperativemedicine.diseasePrognosisSurvival AnalysisNephrectomyKidney NeoplasmsSurgeryTreatment OutcomeFemalebusinessKidney cancerKidney diseaseFollow-Up StudiesBJU international
researchProduct

Progress and controversies in modern treatment of Wilms' tumors.

1995

During the past 25 years the treatment of Wilms' tumors has been refined owing to a series of thoroughly performed clinical studies. The overall prognosis is currently 80% (long-term cures), but different therapeutic issues are still discussed controversially, especially the question of preoperative treatment. A number of different drugs have proved effective in the treatment of Wilms' tumors. It remains to be determined as to which drug combinations are the most effective for which histologic subtype and which stage of disease. It seems that these questions can be answered only if further studies consequently implicate analyses of early and long-term toxicities. The same is true for analys…

NephrologyOncologymedicine.medical_specialtyChemotherapybusiness.industryUrologymedicine.medical_treatmentPostoperative complicationWilms' tumorDiseasemedicine.diseaseCombined Modality TherapyWilms TumorKidney NeoplasmsSurgeryRadiation therapyInternal medicineHistologic typeMedicineHumansStage (cooking)businessChildNeoplasm StagingWorld journal of urology
researchProduct

Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period.

2005

To assess the incidence of complications of conservative renal surgery for renal cell carcinoma in both elective and imperative indications, and its evolution over a 15 year period.From 1988 to 2003, 127 patients underwent partial nephrectomy or tumorectomy for renal cell carcinoma in our department. INDICATIONs were imperative in 42% (n = 53) and elective in 58% (n=74) of cases. Morbidity was retrospectively assessed according to four parameters: 1- Period of surgery: A, from 1988 to 1999 and B, from 2000 to 2003. 2- INDICATION: elective vs. imperative. 3- experience of surgeon: senior vs. junior. 4- Nature of complications: minor or major. Comparative analysis was conducted using Chi-squa…

NephrologyReoperationmedicine.medical_specialtyUrinary FistulaUrologymedicine.medical_treatmentHemorrhageNephrectomyPostoperative ComplicationsRenal cell carcinomaInternal medicineCarcinomamedicineHumansCarcinoma Renal Cellbusiness.industryIncidence (epidemiology)Acute Kidney Injurymedicine.diseaseNephrectomyKidney NeoplasmsSurgeryTreatment OutcomeComplicationbusinessKidney cancerKidney diseaseFollow-Up StudiesEuropean urology
researchProduct

Open Radical Nephrectomy: 35 Years of Experience at the “Luciano Giuliani” Urological Department of the University of Genoa

2006

Objective: Radical nephrectomy remains the gold standard for surgically resectable kidney neoplasms > 4 cm and, in selected cases, also in presence of metastatic disease. We reviewed the records of the patients having surgery at the University of Genoa in the last 35 yr. Methods: We have retrospectively assessed all the radical nephrectomies performed between 1970 and 2005. Among tumours of the kidney subjected to surgical treatment during this period, we found 1105 cases of histologically proven renal cell carcinoma (RCC), 965 of which had records available for the study. The number of cases per year, symptoms at diagnosis, surgical strategy, staging of the tumour, and survival were rev…

Nephrologycancer incidencemedicine.medical_treatmentkidney carcinomamorbiditysepsisRenal cell carcinomacancer diagnosiscancer mortalitynephrectomypostoperative complicationMyocardial infarctioncancer survivaldisease free survivalcancer diagnosiadrenalectomy; article; cancer diagnosis; cancer incidence; cancer mortality; cancer size; cancer staging; cancer surgery; cancer survival; disease free survival; heart infarction; human; kidney carcinoma; lung embolism; lymphadenectomy; metastasis; morbidity; nephrectomy; partial nephrectomy; postoperative complication; priority journal; sepsis; spleen injury; splenectomy; surgical technique; thrombectomyRadical nephrectomyIncidence (epidemiology)articleadrenalectomyRenal cell carcinomaNephrectomypriority journalthrombectomysepsicancer surgerylung embolismmedicine.medical_specialtypartial nephrectomyUrologyheart infarctionsurgical techniquesplenectomyInternal medicinemedicineCarcinomametastasishumanbusiness.industrycancer stagingmedicine.diseaseSurgeryspleen injurycancer sizelymphadenectomySurgerymetastasibusinessKidney cancerKidney diseaseEuropean Urology Supplements
researchProduct

Parenchyma-sparing surgery for renal tumors

1991

Between 1969 und 1989 conservative surgery for kidney tumors was performed in 123 patients. In 49 patients there was an imperative indication for a parenchyma-sparing operation because nephrectomy would have made dialysis obligatory. Thirty-five of these 49 patients show no signs of tumor progression after a mean follow-up of 4.5 years. Known metastases were present in 3 of 6 patients who died as a result of their tumors. In two patients there was a recurrence after 1 and 5 years, respectively, requiring a second organ-preserving operation. In one further patient we suspect that multiple small tumor lesions may be present 2 years after the first operation. In 74 patients with a healthy cont…

Nephrologymedicine.medical_specialtyKidneybusiness.industryUrologymedicine.medical_treatmentEnucleationCancermedicine.diseaseNephrectomySurgerymedicine.anatomical_structureTumor progressionInternal medicinemedicineComplicationbusinessDialysisWorld Journal of Urology
researchProduct

Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society …

2021

This work presents an update on the management of iron deficiency in patients with chronic kidney disease (CKD), either with or without anaemia. A review is made of the recommendations of the guidelines for the treatment of iron deficiency in CKD. It also presents new studies on iron deficiency in patients with CKD, as well as new findings about iron therapy and its impact on clinical outcomes.Anaemia is a common complication of CRF, and is associated with a decrease in the quality of life of the patients, as well as an increase in morbidity and mortality. Iron deficiency (absolute or functional) is common in non-dialysis chronic kidney disease patients, and may cause anaemia or a low respo…

Nephrologymedicine.medical_specialtyPediatricsAnemiaPopulation030232 urology & nephrology030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicinemedicineeducationEnfermedad renal crónicaDéficit férricoeducation.field_of_studyHemoglobinabusiness.industryAnemiaFerropeniaIron deficiencymedicine.diseaseDiseases of the genitourinary system. UrologyNephrologyHeart failureRC870-923businessComplicationHierroKidney diseaseNefrologia
researchProduct

What Could Be a Primary Cause of Multiple Sclerosis: Is It an Autoimmunity Triggered by Chronic Protozoan Infection?

2013

The generally accepted paradigm of multiple sclerosis is the autoimmune one; still, a body of evidence suggests that this disease may actually be triggered by an infectious factor. In this paper, it is hypothesized that multiple sclerosis may actually be a rare complication of a protozoan infection, which is usually asymptomatic but in some susceptible individuals is accompanied by autoimmune attack against the nervous tissue. If multiple sclerosis were actually caused by such an infection, then a microorganism responsible should exhibit several properties: it (i) is transmitted by an arthropod vector; (ii) is characterized by specific metabolism of the lipids; (iii) should be dependent on …

Nervous tissueMultiple sclerosisUsually asymptomaticDiseaseBiologymedicine.diseasemedicine.disease_causeAutoimmunitymedicine.anatomical_structureProtozoan infectionImmunologymedicineComplicationArthropod VectorJournal of Neuroparasitology
researchProduct

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

2008

AbstractThe tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of patients with malignant diseases. To analyze the possible use of these compounds in combination with immunotherapeutic approaches, we analyzed the effects of both inhibitors on the immunostimulatory capacity of human dendritic cells (DCs) and the induction of primary immune responses in vivo. Sorafenib, but not sunitinib, inhibits function of DCs, characterized by reduced secretion of cytokines and expression of CD1a, major histocompatibility complex, and costimulatory molecules in response to TLR ligands as well as by their impaired ability to migrate and stimulate T-cell responses. These inhib…

NiacinamideSorafenibIndolesPyridinesImmunologyAntineoplastic AgentsApoptosisCD8-Positive T-LymphocytesPharmacologyBiologyurologic and male genital diseasesMajor histocompatibility complexT-Lymphocytes RegulatoryBiochemistryPeripheral blood mononuclear cellMiceImmune systemCell MovementIn vivoSunitinibmedicineAnimalsHumansCytotoxic T cellPyrrolesCells CulturedSunitinibPhenylurea CompoundsBenzenesulfonatesGranulocyte-Macrophage Colony-Stimulating FactorDextransDendritic CellsCell BiologyHematologySorafenibEndocytosisfemale genital diseases and pregnancy complicationsMice Inbred C57BLToll-Like Receptor 4biology.proteinCytokinesFemaleInterleukin-4Lymphocyte Culture Test MixedTyrosine kinaseCell DivisionSignal Transductionmedicine.drugBlood
researchProduct

Nipple-sparing mastectomy and breast reconstruction with a deep inferior epigastric perforator flap using thoracodorsal recipient vessels and a low l…

2018

Background Nipple-sparing mastectomy poses challenges in providing esthetically-pleasing immediate autologous breast reconstruction. This study was to investigate the outcomes of nipple-sparing mastectomy with breast reconstruction using free abdominal flaps between two different recipient sites. Methods Between 2010 and 2016, 79 patients who underwent nipple-sparing mastectomy with autologous breast reconstruction using thoracodorsal (TD) vessels in 30 cases or internal mammary (IM) vessels in 49 cases were investigated. Demographics, intraoperative findings, complications, and quality of life using Breast-Q questionnaire were compared between two groups. Results All flap survived. There w…

Nipple-Sparing MastectomyAdultmedicine.medical_specialtymedicine.medical_treatmentMammaplastyBreast Neoplasms030230 surgeryFree Tissue Flaps03 medical and health sciencesYoung Adult0302 clinical medicineAbdominal flapsThoracic Arteriesbreast reconstruction deep inferior epigastric perforator internal mammary vessels quality of life thoracodorsal vesselsmedicineHumansMammary ArteriesMastectomyAgedbreast reconstruction; deep inferior epigastric perforator; internal mammary vessels; quality of life; thoracodorsal vessels; Adult; Aged; Anastomosis Surgical; Breast Neoplasms; Epigastric Arteries; Female; Follow-Up Studies; Free Tissue Flaps; Humans; Mammaplasty; Mammary Arteries; Mastectomy; Middle Aged; Nipples; Organ Sparing Treatments; Perforator Flap; Prognosis; Quality of Life; Thoracic Arteries; Young Adultbusiness.industryAnastomosis SurgicalCosmesisGeneral MedicineMiddle AgedPrognosisEpigastric ArteriesSurgerymedicine.anatomical_structureOncology030220 oncology & carcinogenesisNipplesMammaplastyQuality of LifeSurgeryFemalebusinessComplicationBreast reconstructionOrgan Sparing TreatmentsPerforator FlapMastectomyArteryFollow-Up Studies
researchProduct

Priekšlaicīgu dzemdību izraisītu grūtniecības komplikāciju izvērtējums.

2017

Cēlonis: Grūtniecības komplikācijas ir galvenie iemesli mātes un augļa mortality.Pregnancy komplikāciju mainās dažādās populāciju, BMI un vecuma grupā. Saskaņā ar Global Health observatoriju, kuri katru dienu 2015. gadā, aptuveni 830 sievietes nomira dēļ komplikācijas grūtniecības un bērna piedzimšanas. Tāpēc ir ļoti svarīgi, lai analizētu grūtniecības komplikācijas gan priekšlaicīgas dzemdības un normālu termiņa piegāde (vadības grupa). Mērķi: Pētījuma mērķis ir analizēt dažas grūtniecības komplikācijas un salīdzināt tos no priekšlaicīgas dzemdības un kontroles grupu, un salīdzināt tos ar vecuma grupu un ĶMI grupu. Materiāli un metodes: Pētījums modelis ietver datus, kas savākti no Rig…

Normal term deliveryPregnancy complicationPreterm deliveryPlacental ProblemsPreeclampsiaMedicīna
researchProduct